Evidence map›Paper›PMID 41395324›Full record

ArticleIJTLD open2025

Rapid clinical detection of mycobacterial infections using M-Typer and flow-injection tandem mass spectrometry.

A Głogowska, K Majewski, B Szulc, K Kowalski, E Augustynowicz-Kopeć

Abstract read
In one paragraph

Article in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A GłogowskaDepartment of Microbiology, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
K MajewskiCentre of Clinical Medicine DiMedical Ltd., Lodz, Poland.
B SzulcCentre of Clinical Medicine DiMedical Ltd., Lodz, Poland.
K KowalskiCentre of Clinical Medicine DiMedical Ltd., Lodz, Poland.
E Augustynowicz-KopećDepartment of Microbiology, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe evaluated the utility of the M-Typer® assay, based on flow-injection tandem mass spectrometry mycolic acid profiling, in the diagnosis of TB and other mycobacterial infections.

methodsThe ability of the M-Typer® assay to identify

resultsThe M-Typer® assay correctly classified all clinical strains as either DISCUSSION: The M-Typer® assay demonstrated diagnostic accuracy comparable to established methods, supporting its potential role in clinical microbiology for rapid, direct detection and species-level identification of mycobacteria. Nevertheless, its relatively low PPV indicates the need for further optimisation and validation in diverse clinical settings.

Indexed as

FIA/MS-MSmycobacteriosesMycobacteriummycolic acidstuberculosis

Identifiers

PMID41395324
PMCPMC12699965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.